Fig. 2: Longitudinal changes in anthropometry and metabolic health among participants treated with FMT or placebo. | Nature Communications

Fig. 2: Longitudinal changes in anthropometry and metabolic health among participants treated with FMT or placebo.

From: Long-term health outcomes in adolescents with obesity treated with faecal microbiota transplantation: 4-year follow-up

Fig. 2: Longitudinal changes in anthropometry and metabolic health among participants treated with FMT or placebo.

A Individual changes (Δ) in anthropometric and metabolic outcomes at 4 years compared to baseline. Points represent individual participants. The boxes represent the interquartile range (IQR) split by the median, with whiskers expanding up to 1.5× the IQR. The dashed red line at 0 represents the reference baseline value. *p < 0.05 and **p < 0.01 for between-group differences, derived from linear models; p-values are nominal (unadjusted for multiple comparisons) and two-sided. Exact sample sizes for each analysis are indicated Fig. 1. BMI body mass index, FMT faecal microbiota transplantation, HDL high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein; and metabolic syndrome severity scores (MetSSS). B Weight and C MetSSS over the full study period, including only participants (FMT, blue; Placebo, yellow) who returned for the 4-year follow-up.

Back to article page